Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Choline tetrathiomolybdate

EU orphan designation number: EU/3/12/1089   
Active ingredient: Choline tetrathiomolybdate
Indication: Treatment of Wilson's disease
Sponsor: Wilson Therapeutics AB
Kungsgatan 3, SE-111 43 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/142/12 (2013)478 of 24/01/2013
1/08/2014 Transfer of orphan designation EMA/OD/142/12/T/01 (2014)5575 of 30/07/2014
2/03/2018 Change of name and/or address of sponsor